Ceftiocyl Fluid 50 mg/ml, suspension for injection for pigs and cattle

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Nopērc to tagad

Lejuplādēt Produkta apraksts (SPC)
28-09-2019

Aktīvā sastāvdaļa:

Ceftiofur hydrochloride

Pieejams no:

Vetoquinol Ireland Limited

ATĶ kods:

QJ01DD90

SNN (starptautisko nepatentēto nosaukumu):

Ceftiofur hydrochloride

Deva:

50 milligram(s)/millilitre

Zāļu forma:

Suspension for injection

Receptes veids:

POM: Prescription Only Medicine as defined in relevant national legislation

Ārstniecības joma:

ceftiofur

Autorizācija statuss:

Authorised

Autorizācija datums:

2017-12-08

Produkta apraksts

                                Health Products Regulatory Authority
27 September 2019
CRN009282
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Ceftiocyl Fluid 50 mg/ml, suspension for injection for pigs and cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml contains:
ACTIVE SUBSTANCE(S):
Ceftiofur (as hydrochloride) 50.0 mg
EXCIPIENT(S):
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection.
Slightly yellow to slightly pink, milky suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Infections associated with bacteria sensitive to ceftiofur:
In pigs:
For the treatment of bacterial respiratory disease associated with
Pasteurella multocida, Actinobacillus pleuropneumoniae and
Streptococcus suis.
In cattle:
For the treatment of bacterial respiratory disease associated with
Mannheimia haemolytica, Pasteurella multocida and
Histophilus somni.
For the treatment of acute interdigital necrobacillosis, (panaritium,
foot rot), associated with Fusobacterium necrophorum and
Bacteroides melaninogenicus.
For treatment of the bacterial component of acute post-partum
(puerperal) metritis within 10 days after calving associated with
Escherichia coli, Trueperella pyogenes (former Arcanobacterium
pyogenes) and Fusobacterium necrophorum, sensitive to
ceftiofur, where treatment with another antimicrobial has failed.
4.3 CONTRAINDICATIONS
Do not inject intravenously.
Do not use in poultry (including eggs) due to the risk of spread of
antimicrobial resistance to humans. Do not use in cases of
hypersensitivity to ceftiofur, to any other β-lactam antibiotics, or
to any of the excipients.
Do not use in cases of known resistance to ceftiofur or other
β-lactam antibiotics.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
Health Products Regulatory Authority
27 September 2019
CRN009282
Page 2 of 6
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
In case of the occurrence of allergi
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu